series-a
Stage
1
Investors
About
Mestag Therapeutics develops therapies targeting fibrotic diseases by using novel protein engineering technologies to modulate immune responses and tissue remodeling.
Explore Mestag Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.